Report Detail
COVID-19 Impact on Global OTC Anti-Infective Products Market Insights, Forecast to 2026
- RnM3985278 |
- 03 June, 2020 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the OTC Anti-Infective Products market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the OTC Anti-Infective Products industry.
Based on our recent survey, we have several different scenarios about the OTC Anti-Infective Products YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of OTC Anti-Infective Products will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global OTC Anti-Infective Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global OTC Anti-Infective Products market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global OTC Anti-Infective Products market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global OTC Anti-Infective Products market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global OTC Anti-Infective Products market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global OTC Anti-Infective Products market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global OTC Anti-Infective Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global OTC Anti-Infective Products market.
The following manufacturers are covered in this report:
GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
NanoViricides
Novabay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma
OTC Anti-Infective Products Breakdown Data by Type
Antifungals
Antiseptic
Antiparasitics
OTC Anti-Infective Products Breakdown Data by Application
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
1 Study Coverage
- 1.1 OTC Anti-Infective Products Product Introduction
- 1.2 Market Segments
- 1.3 Key OTC Anti-Infective Products Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global OTC Anti-Infective Products Market Size Growth Rate by Type
- 1.4.2 Antifungals
- 1.4.3 Antiseptic
- 1.4.4 Antiparasitics
- 1.5 Market by Application
- 1.5.1 Global OTC Anti-Infective Products Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Drug Stores
- 1.5.4 Retail Stores
- 1.5.5 E-Commerce
- 1.6 Coronavirus Disease 2019 (Covid-19): OTC Anti-Infective Products Industry Impact
- 1.6.1 How the Covid-19 is Affecting the OTC Anti-Infective Products Industry
- 1.6.1.1 OTC Anti-Infective Products Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and OTC Anti-Infective Products Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for OTC Anti-Infective Products Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the OTC Anti-Infective Products Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global OTC Anti-Infective Products Market Size Estimates and Forecasts
- 2.1.1 Global OTC Anti-Infective Products Revenue 2015-2026
- 2.1.2 Global OTC Anti-Infective Products Sales 2015-2026
- 2.2 OTC Anti-Infective Products Market Size by Region: 2020 Versus 2026
- 2.2.1 Global OTC Anti-Infective Products Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global OTC Anti-Infective Products Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global OTC Anti-Infective Products Competitor Landscape by Players
- 3.1 OTC Anti-Infective Products Sales by Manufacturers
- 3.1.1 OTC Anti-Infective Products Sales by Manufacturers (2015-2020)
- 3.1.2 OTC Anti-Infective Products Sales Market Share by Manufacturers (2015-2020)
- 3.2 OTC Anti-Infective Products Revenue by Manufacturers
- 3.2.1 OTC Anti-Infective Products Revenue by Manufacturers (2015-2020)
- 3.2.2 OTC Anti-Infective Products Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global OTC Anti-Infective Products Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by OTC Anti-Infective Products Revenue in 2019
- 3.2.5 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 OTC Anti-Infective Products Price by Manufacturers
- 3.4 OTC Anti-Infective Products Manufacturing Base Distribution, Product Types
- 3.4.1 OTC Anti-Infective Products Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers OTC Anti-Infective Products Product Type
- 3.4.3 Date of International Manufacturers Enter into OTC Anti-Infective Products Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global OTC Anti-Infective Products Market Size by Type (2015-2020)
- 4.1.1 Global OTC Anti-Infective Products Sales by Type (2015-2020)
- 4.1.2 Global OTC Anti-Infective Products Revenue by Type (2015-2020)
- 4.1.3 OTC Anti-Infective Products Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global OTC Anti-Infective Products Market Size Forecast by Type (2021-2026)
- 4.2.1 Global OTC Anti-Infective Products Sales Forecast by Type (2021-2026)
- 4.2.2 Global OTC Anti-Infective Products Revenue Forecast by Type (2021-2026)
- 4.2.3 OTC Anti-Infective Products Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global OTC Anti-Infective Products Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global OTC Anti-Infective Products Market Size by Application (2015-2020)
- 5.1.1 Global OTC Anti-Infective Products Sales by Application (2015-2020)
- 5.1.2 Global OTC Anti-Infective Products Revenue by Application (2015-2020)
- 5.1.3 OTC Anti-Infective Products Price by Application (2015-2020)
- 5.2 OTC Anti-Infective Products Market Size Forecast by Application (2021-2026)
- 5.2.1 Global OTC Anti-Infective Products Sales Forecast by Application (2021-2026)
- 5.2.2 Global OTC Anti-Infective Products Revenue Forecast by Application (2021-2026)
- 5.2.3 Global OTC Anti-Infective Products Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America OTC Anti-Infective Products by Country
- 6.1.1 North America OTC Anti-Infective Products Sales by Country
- 6.1.2 North America OTC Anti-Infective Products Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America OTC Anti-Infective Products Market Facts & Figures by Type
- 6.3 North America OTC Anti-Infective Products Market Facts & Figures by Application
7 Europe
- 7.1 Europe OTC Anti-Infective Products by Country
- 7.1.1 Europe OTC Anti-Infective Products Sales by Country
- 7.1.2 Europe OTC Anti-Infective Products Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe OTC Anti-Infective Products Market Facts & Figures by Type
- 7.3 Europe OTC Anti-Infective Products Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific OTC Anti-Infective Products by Region
- 8.1.1 Asia Pacific OTC Anti-Infective Products Sales by Region
- 8.1.2 Asia Pacific OTC Anti-Infective Products Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Type
- 8.3 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America OTC Anti-Infective Products by Country
- 9.1.1 Latin America OTC Anti-Infective Products Sales by Country
- 9.1.2 Latin America OTC Anti-Infective Products Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America OTC Anti-Infective Products Market Facts & Figures by Type
- 9.3 Central & South America OTC Anti-Infective Products Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa OTC Anti-Infective Products by Country
- 10.1.1 Middle East and Africa OTC Anti-Infective Products Sales by Country
- 10.1.2 Middle East and Africa OTC Anti-Infective Products Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Type
- 10.3 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Application
11 Company Profiles
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Corporation Information
- 11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered
- 11.1.5 GlaxoSmithKline Recent Development
- 11.2 Merck
- 11.2.1 Merck Corporation Information
- 11.2.2 Merck Description, Business Overview and Total Revenue
- 11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Merck OTC Anti-Infective Products Products Offered
- 11.2.5 Merck Recent Development
- 11.3 Pfizer
- 11.3.1 Pfizer Corporation Information
- 11.3.2 Pfizer Description, Business Overview and Total Revenue
- 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Pfizer OTC Anti-Infective Products Products Offered
- 11.3.5 Pfizer Recent Development
- 11.4 Novartis
- 11.4.1 Novartis Corporation Information
- 11.4.2 Novartis Description, Business Overview and Total Revenue
- 11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Novartis OTC Anti-Infective Products Products Offered
- 11.4.5 Novartis Recent Development
- 11.5 Abbott
- 11.5.1 Abbott Corporation Information
- 11.5.2 Abbott Description, Business Overview and Total Revenue
- 11.5.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Abbott OTC Anti-Infective Products Products Offered
- 11.5.5 Abbott Recent Development
- 11.6 Sanofi
- 11.6.1 Sanofi Corporation Information
- 11.6.2 Sanofi Description, Business Overview and Total Revenue
- 11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Sanofi OTC Anti-Infective Products Products Offered
- 11.6.5 Sanofi Recent Development
- 11.7 Bristol-Myers Squibb
- 11.7.1 Bristol-Myers Squibb Corporation Information
- 11.7.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
- 11.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Bristol-Myers Squibb OTC Anti-Infective Products Products Offered
- 11.7.5 Bristol-Myers Squibb Recent Development
- 11.8 Roche
- 11.8.1 Roche Corporation Information
- 11.8.2 Roche Description, Business Overview and Total Revenue
- 11.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Roche OTC Anti-Infective Products Products Offered
- 11.8.5 Roche Recent Development
- 11.9 NanoViricides
- 11.9.1 NanoViricides Corporation Information
- 11.9.2 NanoViricides Description, Business Overview and Total Revenue
- 11.9.3 NanoViricides Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 NanoViricides OTC Anti-Infective Products Products Offered
- 11.9.5 NanoViricides Recent Development
- 11.10 Novabay Pharmaceuticals
- 11.10.1 Novabay Pharmaceuticals Corporation Information
- 11.10.2 Novabay Pharmaceuticals Description, Business Overview and Total Revenue
- 11.10.3 Novabay Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Novabay Pharmaceuticals OTC Anti-Infective Products Products Offered
- 11.10.5 Novabay Pharmaceuticals Recent Development
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Corporation Information
- 11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered
- 11.1.5 GlaxoSmithKline Recent Development
- 11.12 Basilea Pharmaceutica
- 11.12.1 Basilea Pharmaceutica Corporation Information
- 11.12.2 Basilea Pharmaceutica Description, Business Overview and Total Revenue
- 11.12.3 Basilea Pharmaceutica Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Basilea Pharmaceutica Products Offered
- 11.12.5 Basilea Pharmaceutica Recent Development
- 11.13 MerLion Pharma
- 11.13.1 MerLion Pharma Corporation Information
- 11.13.2 MerLion Pharma Description, Business Overview and Total Revenue
- 11.13.3 MerLion Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 MerLion Pharma Products Offered
- 11.13.5 MerLion Pharma Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 OTC Anti-Infective Products Market Estimates and Projections by Region
- 12.1.1 Global OTC Anti-Infective Products Sales Forecast by Regions 2021-2026
- 12.1.2 Global OTC Anti-Infective Products Revenue Forecast by Regions 2021-2026
- 12.2 North America OTC Anti-Infective Products Market Size Forecast (2021-2026)
- 12.2.1 North America: OTC Anti-Infective Products Sales Forecast (2021-2026)
- 12.2.2 North America: OTC Anti-Infective Products Revenue Forecast (2021-2026)
- 12.2.3 North America: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
- 12.3 Europe OTC Anti-Infective Products Market Size Forecast (2021-2026)
- 12.3.1 Europe: OTC Anti-Infective Products Sales Forecast (2021-2026)
- 12.3.2 Europe: OTC Anti-Infective Products Revenue Forecast (2021-2026)
- 12.3.3 Europe: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific OTC Anti-Infective Products Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: OTC Anti-Infective Products Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: OTC Anti-Infective Products Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: OTC Anti-Infective Products Market Size Forecast by Region (2021-2026)
- 12.5 Latin America OTC Anti-Infective Products Market Size Forecast (2021-2026)
- 12.5.1 Latin America: OTC Anti-Infective Products Sales Forecast (2021-2026)
- 12.5.2 Latin America: OTC Anti-Infective Products Revenue Forecast (2021-2026)
- 12.5.3 Latin America: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa OTC Anti-Infective Products Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: OTC Anti-Infective Products Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: OTC Anti-Infective Products Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key OTC Anti-Infective Products Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 OTC Anti-Infective Products Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global OTC Anti-Infective Products. Industry analysis & Market Report on COVID-19 Impact on Global OTC Anti-Infective Products is a syndicated market report, published as COVID-19 Impact on Global OTC Anti-Infective Products Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global OTC Anti-Infective Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
